➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts

Last Updated: September 23, 2020

DrugPatentWatch Database Preview

Patent: 7,749,999

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,749,999
Title:Alpha-ketoamides and derivatives thereof
Abstract: The present invention provides low molecular weight compounds useful as cytokine inhibitors, and compositions thereof. In particular, compounds of the invention are useful as anti-inflammatory agents. There are further provided methods for the preparation of such agents and their use in preventing or treating conditions mediated by cytokines such as arthritis.
Inventor(s): Boman; Erik (Chula Vista, CA), Ceide; Susana Conde (San Diego, CA), Dahl; Russell (Carlsbad, CA), Delaet; Nancy G. J. (San Diego, CA), Ernst; Justin (San Diego, CA), Montalban; Antonio Garrido (San Diego, CA), Nakanishi; Hiroshi (San Diego, CA), Roberts; Edward (Fallbrook, CA), Saiah; Eddine (La Jolla, CA), Sullivan; Robert (Vista, CA), Wang; Zhinjun (San Diego, CA), Kahl; Jeffrey (San Diego, CA), Larson; Christopher (San Diego, CA)
Assignee: Itherx Pharmaceuticals, Inc. (San Diego, CA)
Application Number:10/939,324
Patent Claims:see list of patent claims

Details for Patent 7,749,999

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Centocor Inc REMICADE infliximab VIAL 103772 001 1998-08-24   Start Trial Itherx Pharmaceuticals, Inc. (San Diego, CA) 2023-09-11 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.